| # | Drug | Count |
|---|---|---|
| 0 | DAPSONE | 17 |
| 1 | DAPSONE GEL, 5% | 17 |
| 2 | DASPONE | 17 |
| 3 | CLOFAZIMINE | 16 |
| 4 | METHOTREXATE SODIUM | 12 |
| 5 | HYDROXYCHLOROQUINE | 10 |
| 6 | METHOTREXATE | 10 |
| 7 | RIFAMPIN | 10 |
| 8 | RIFAMPICIN | 7 |
| 9 | CARBOPLATIN | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CLOFAZIMINE | 16 | 0.0025 |
| 1 | DASPONE | 17 | 0.0017 |
| 2 | DAPSONE GEL, 5% | 17 | 0.0017 |
| 3 | DAPSONE | 17 | 0.0016 |
| 4 | CYCLOSERINE | 2 | 0.0009 |
| 5 | RIFAMPICIN | 7 | 0.0007 |
| 6 | RIFAMPIN | 10 | 0.0007 |
| 7 | EFAVIRENZ | 5 | 0.0005 |
| 8 | OFLOXACIN OTIC SOLUTION | 2 | 0.0003 |
| 9 | OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3% | 2 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sulfone [EPC] | 17 | 0.0016 |
| 1 | Antimycobacterial [EPC] | 17 | 0.0007 |
| 2 | Rifamycin Antibacterial [EPC] | 10 | 0.0003 |
| 3 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0002 |
| 4 | Quinolone Antimicrobial [EPC] | 2 | 0.0002 |
| 5 | Oxazolidinone Antibacterial [EPC] | 2 | 0.0001 |
| 6 | Microtubule Inhibitor [EPC] | 5 | 0.0000 |
| 7 | Platinum-based Drug [EPC] | 8 | 0.0000 |
| 8 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0000 |
| 9 | Nucleoside Analog Antiviral [EPC] | 2 | 0.0000 |